Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Kenji Yasukawa
Age : 61
Country of residence : Unknown
Linked companies : Astellas Pharma Inc.

Biography of Kenji Yasukawa 
Presently, Kenji Yasukawa occupies the position of President, CEO & Representative Director at Astellas Pharma, Inc. and Chairman & Chief Executive Officer for Astellas Pharma SpA, Chief Executive Officer of Astellas Pharma US, Inc. and President & Chief Executive Officer at Astellas US LLC (which are all subsidiaries of Astellas Pharma, Inc.). In his past career he occupied the position of Global Head-Urology Therapeutic Areas at Astellas Pharma Global Development, Inc.


Current positions of Kenji Yasukawa 
Kenji Yasukawa : Personal Network 
Most Read News 
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
RE
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
RE
10/11JAMIE DIMON : JPMorgan's Dimon blasts bitcoin as 'worthless', due for regulation
RE
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
RE
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
RE
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
RE
10/18MATTHEW MOULDING : THG's Moulding gives up 'golden share' after stock tumbles
RE
10/12JACK MA : Billionaire Alibaba founder Jack Ma reappears in Hong Kong - sources
RE
10/09ELON MUSK : First Berlin Teslas could come next month, Musk tells fans
RE
10/19JACK MA : Alibaba's Ma in Europe on study tour - SCMP
RE
More news


© 2021 People and Ownership :   
Kenji Yasukawa : Connections 


Latest news about Kenji Yasukawa 
2019Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
RE
2018Astellas Pharma Inc. Appoints Bernhardt Zeiher, as New Chief Medical Officer
CI
2018Astellas Pharma Inc. Announces Board Changes; Effective Date from April 1, 2018
CI
More news